AU5521099A - Use of lithium gluconate for making a medicine for treating herpes and seborrheic dermatitis - Google Patents

Use of lithium gluconate for making a medicine for treating herpes and seborrheic dermatitis

Info

Publication number
AU5521099A
AU5521099A AU55210/99A AU5521099A AU5521099A AU 5521099 A AU5521099 A AU 5521099A AU 55210/99 A AU55210/99 A AU 55210/99A AU 5521099 A AU5521099 A AU 5521099A AU 5521099 A AU5521099 A AU 5521099A
Authority
AU
Australia
Prior art keywords
seborrheic dermatitis
medicine
making
treating herpes
lithium gluconate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU55210/99A
Inventor
Jacques Bodin
Brigitte Dreno
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LABCATAL
Original Assignee
LABCATAL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LABCATAL filed Critical LABCATAL
Publication of AU5521099A publication Critical patent/AU5521099A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The invention concerns the therapeutic use of lithium gluconate for making a medicine for treating herpes and seborrheic dermatitis, preferably in a composition designed for topical administration, the lithium gluconate content ranging between 1 and 50 wt. % relative to the composition total weight. The invention is useful for treating herpes and seborrheic dermatitis.
AU55210/99A 1998-09-03 1999-09-03 Use of lithium gluconate for making a medicine for treating herpes and seborrheic dermatitis Abandoned AU5521099A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9811025A FR2783424B1 (en) 1998-09-03 1998-09-03 USE OF LITHIUM GLUCONATE IN THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF HERPES AND SEBORRHEIC DERMITIS
FR9811025 1998-09-03
PCT/FR1999/002108 WO2000013649A2 (en) 1998-09-03 1999-09-03 Use of lithium gluconate for making a medicine for treating herpes and seborrheic dermatitis

Publications (1)

Publication Number Publication Date
AU5521099A true AU5521099A (en) 2000-03-27

Family

ID=9530089

Family Applications (1)

Application Number Title Priority Date Filing Date
AU55210/99A Abandoned AU5521099A (en) 1998-09-03 1999-09-03 Use of lithium gluconate for making a medicine for treating herpes and seborrheic dermatitis

Country Status (9)

Country Link
EP (1) EP1107766B1 (en)
AT (1) ATE234620T1 (en)
AU (1) AU5521099A (en)
CA (1) CA2341566C (en)
DE (1) DE69906091T2 (en)
ES (1) ES2193741T3 (en)
FR (1) FR2783424B1 (en)
PT (1) PT1107766E (en)
WO (1) WO2000013649A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6416981B1 (en) 2000-05-23 2002-07-09 Nec Partnership Production of gluconate salts
EP1948236B1 (en) * 2005-09-27 2021-03-03 Special Water Patents B.V. Methods and compositions for treatment of skin

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8318912D0 (en) * 1983-07-13 1983-08-17 Horrobin D F Compositions for treatment of skin/hair
GB8319766D0 (en) * 1983-07-22 1983-08-24 Graham N B Controlled release device
GB9023701D0 (en) * 1990-10-31 1990-12-12 Efamol Holdings Medical treatment
CA2158137C (en) * 1993-03-12 2004-03-02 James Derek Birchall Therapeutic compositions containing a lithium compound and silica

Also Published As

Publication number Publication date
FR2783424B1 (en) 2002-10-04
EP1107766B1 (en) 2003-03-19
ATE234620T1 (en) 2003-04-15
DE69906091T2 (en) 2003-11-20
PT1107766E (en) 2003-08-29
ES2193741T3 (en) 2003-11-01
WO2000013649A2 (en) 2000-03-16
EP1107766A2 (en) 2001-06-20
WO2000013649A3 (en) 2000-07-20
FR2783424A1 (en) 2000-03-24
CA2341566A1 (en) 2000-03-16
CA2341566C (en) 2009-11-24
DE69906091D1 (en) 2003-04-24

Similar Documents

Publication Publication Date Title
AU3168395A (en) Therapeutic vitamin-calcium combination in unitary galenic tablet form, method for preparing same and use thereof
WO2003024387A3 (en) Method and pharmaceutical composition for treating inflammation
MY111260A (en) Pharmaceutical composition for the treatment of nicotine dependence
RO116342B1 (en) Oral liquid pharmaceutical composition
MY132705A (en) Novel compounds with analgesic effect
AU2002216748A1 (en) Method of treatment of seborrheic dermatitis
WO1995031991A3 (en) Use of magnesium-based products for the treatment or prophylaxis of neoplastic and autoimmune diseases
CA2158036A1 (en) 3,4-Diarylchromans for Treatment of Dermatitis
WO1999061010A3 (en) Treatment of infertility with cam-increasing compounds alone or in combination with at least one meiosis-stimulating compound
NZ326345A (en) Composition containing diosgenin
AU5521099A (en) Use of lithium gluconate for making a medicine for treating herpes and seborrheic dermatitis
AU1400895A (en) 2,3-diaryl-1-benzopyrans for treating dermatitis
IL112019A (en) Pharmaceutical compositions for topical treatment of psoriasis
GB2353214A (en) Topical Composition
RO116345B1 (en) Analgesic vegetable composition
IT1264428B1 (en) Pharmaceutical compositions for the treatment of psoriasis

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase